Yellow fever SDV 5S
Ended Awarded Last action
- Contract number
- SPE2DR26FBTGX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,541
Award facts
- Contract value 100% obligated
- $44,540.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $44,540.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Yellow Fever SDV 5S products. The delivery order, designated as contract 4570332308, is structured as a firm fixed-price agreement with an ultimate completion date of January 6, 2026, and was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will perform the work at its Park Ridge facility and deliver the ordered pharmaceutical products to support Department of Defense medical supply requirements.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy established to provide comprehensive pharmaceutical supply support to military healthcare facilities worldwide. The parent IDC, valued at $499.999 billion with a completion date of December 31, 2036, was awarded to DMS Pharmaceutical Group on November 13, 2025, and authorizes the issuance of firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables. The contractor's established performance on numerous prior delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FBTGX?
SPE2DR26FBTGX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26FBTGX worth?
The government has obligated $44,541 on SPE2DR26FBTGX.
Is contract SPE2DR26FBTGX an order under another contract?
Yes. SPE2DR26FBTGX is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTGX competed?
The extent of competition for SPE2DR26FBTGX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award